Search

everythinglearnresearchcommunity

for

Search:↓

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Burn reconstruction improves with new techniques, materials, and tissue engineering.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Prolactin slows down hair growth in mice.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Plant compounds may offer a promising alternative for cancer treatment.

Facial rejuvenation surgery has evolved to yield natural results with low complication rates, and more men and older patients are choosing this surgery.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Hairless mice lack fur due to a genetic mutation affecting skin response, not hormone issues.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Mice without the Sp6 gene have problems developing several body parts, including hair, teeth, limbs, and lungs.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.